Recombinant Human Cfi Protein，His

Cfi, or Cyclophilin A, is a well-studied protein known for its role as a peptidyl-prolyl isomerase and its involvement in various cellular functions, including protein folding, trafficking, and regulation of immune responses. Research on Cfi has gained momentum due to its implications in several diseases, particularly in HIV, where it aids viral replication by interacting with viral proteins. Furthermore, Cfi has been implicated in cancer progression, neurodegenerative diseases, and inflammation, highlighting its potential as a therapeutic target. Advances in molecular biology and structural biology techniques have paved the way for the detailed study of Cfi and its interactions within cellular pathways. The re-engineering of Cfi to create recombinant proteins has enabled scientists to explore its structural dynamics and functional mechanisms more thoroughly. By producing Cfi in heterologous systems, researchers can generate large quantities of the protein for functional assays and high-resolution structural analyses, facilitating a deeper understanding of its role in disease pathology and paving the way for the development of small-molecule inhibitors or other therapeutics aimed at modulating its activity. Investigating the various isoforms and post-translational modifications of Cfi could also shed light on its multifaceted roles within the cell. Overall, the study of Cfi as a recombinant protein represents a significant avenue in biomedical research, promising novel insights into its functions and potential therapeutic applications.